Impact BioMedical, Inc. is a holding company, which engages in the discovery and development of products and treatment options in specialty biopharmaceuticals and consumer healthcare. The firm focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases. It is also involved in developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. The company was founded on October 16, 2018 and is headquartered in Houston, TX. |  |
|
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| DSS, INC. | 10% Owner | May 22 '25 | Sale | 0.55 | 115,600 | 63,476 | 45,400 | May 27 04:35 PM | | DSS, INC. | 10% Owner | May 27 '25 | Sale | 0.54 | 45,400 | 24,530 | 0 | May 27 04:35 PM | | DSS, INC. | 10% Owner | Apr 04 '25 | Sale | 0.95 | 890,800 | 845,013 | 161,100 | Apr 07 09:59 PM | | Chan Heng Fai Ambrose | Director | Apr 03 '25 | Sale | 0.49 | 351,555 | 174,020 | 0 | Apr 07 05:18 PM | | Chan Heng Fai Ambrose | Director | Apr 02 '25 | Sale | 0.60 | 884,776 | 533,636 | 351,555 | Apr 04 05:15 PM | | Chan Heng Fai Ambrose | Director | Apr 03 '25 | Sale | 0.67 | 624,917 | 416,484 | 0 | Apr 04 05:15 PM | | Chan Heng Fai Ambrose | Director | Apr 04 '25 | Sale | 0.96 | 180,000 | 172,800 | 0 | Apr 04 05:15 PM | | Chan Heng Fai Ambrose | Director | Apr 01 '25 | Sale | 1.17 | 2,226,918 | 2,604,421 | 734,058 | Apr 02 09:01 PM | | Chan Heng Fai Ambrose | Director | Mar 31 '25 | Sale | 1.03 | 300,000 | 308,400 | 1,253,904 | Apr 02 09:01 PM | | DSS, INC. | 10% Owner | Mar 21 '25 | Sale | 3.30 | 499,800 | 1,649,540 | 0 | Mar 28 05:25 PM | | DSS, INC. | 10% Owner | Mar 26 '25 | Sale | 3.13 | 58,139 | 182,134 | 1,099,481 | Mar 28 05:25 PM | | DSS, INC. | 10% Owner | Mar 27 '25 | Sale | 2.50 | 47,681 | 119,255 | 1,051,800 | Mar 28 05:25 PM | | DSS, INC. | 10% Owner | Mar 20 '25 | Buy | 1.55 | 200 | 310 | 53,280 | Mar 24 08:00 PM | | DSS, INC. | 10% Owner | Mar 20 '25 | Sale | 4.68 | 53,280 | 249,350 | 0 | Mar 24 08:00 PM | | DSS, INC. | 10% Owner | Dec 02 '24 | Sale | 2.90 | 20 | 58 | 53,080 | Mar 24 08:00 PM | | Heuszel Frank D | Chief Executive Officer | Dec 05 '24 | Buy | 2.26 | 500 | 1,129 | 97,344 | Dec 09 04:05 PM | | Heuszel Frank D | Chief Executive Officer | Nov 27 '24 | Buy | 2.61 | 500 | 1,305 | 96,844 | Dec 03 09:51 PM | | Heuszel Frank D | Chief Executive Officer | Nov 26 '24 | Buy | 2.61 | 1,050 | 2,739 | 96,344 | Dec 03 09:49 PM | | DSS, INC. | 10% Owner | Nov 18 '24 | Sale | 3.02 | 5,000 | 15,085 | 53,100 | Nov 22 04:33 PM | | DSS, INC. | 10% Owner | Nov 12 '24 | Sale | 2.76 | 500 | 1,378 | 58,300 | Nov 22 04:33 PM | | DSS, INC. | 10% Owner | Nov 13 '24 | Sale | 2.80 | 200 | 560 | 58,100 | Nov 22 04:33 PM | | DSS, INC. | 10% Owner | Sep 18 '24 | Buy | 2.33 | 1,000 | 2,330 | 58,800 | Sep 19 07:07 PM | | DSS, INC. | 10% Owner | Sep 16 '24 | Buy | 2.69 | 50,000 | 134,500 | 50,000 | Sep 18 08:53 PM | | DSS, INC. | 10% Owner | Sep 17 '24 | Buy | 2.40 | 7,800 | 18,720 | 57,800 | Sep 18 08:53 PM |
|
